1. Home
  2. Healthcare & Pharmaceuticals
  3. influenza-diagnostics-global-market-43247
post image

Influenza Diagnostics Global Market 2022 Opportunities And Strategies To 2031 Including: (By Traditional Diagnostic Tests: Rapid Influenza Diagnostics Tests (RIDT); Viral Culture; DFA; Serological Assays); By Molecular Diagnostic Tests; By End User

  • Report ID: 43247
  • Date: Sep, 2022
  • Pages: 303
  • Category: Healthcare & Pharmaceuticals

 

Influenza Diagnostics Global Market Opportunities And Strategies To 2031 from Altus Market Research provides the strategists; marketers and senior management with the critical information they need to assess the global influenza diagnostics market as it emerges from the COVID-19 shut down.

The global influenza diagnostics market reached a value of nearly $2,269.5 million in 2021, having increased at a compound annual growth rate (CAGR) of 16.5% since 2016. The market is expected to grow from $2,269.5 million in 2021 to $3,154.6 million in 2026 at a rate of 6.8%. The market is then expected to grow at a CAGR of 6.8% from 2026 and reach $4,374.5 million in 2031.  

Growth in the historic period resulted from a rise in initiatives towards influenza, increased healthcare expenditure, rising air pollution levels, strong economic growth in emerging markets and increased aging population. Factors that negatively affected growth in the historic period were low healthcare access. 

Going forward, a rise in healthcare expenditure, a rise in healthcare expenditure, increasing government support and increasing FDA approvals for influenza testing will drive market growth. Factors that could hinder the growth of the influenza diagnostics market in the future include a rise in interest rates, lack of healthcare infrastructure and false results. 

The influenza diagnostics market is segmented by traditional diagnostic tests into rapid influenza diagnostics tests (RIDT), viral culture, DFA, serological assays, other traditional diagnostic tests. The rapid influenza diagnostics tests (RIDT) market was the largest segment of the influenza diagnostic market segmented by traditional diagnostic tests, accounting for 40.1% of the total in 2021 and viral culture segment is expected to be the fastest growing segment going forward, at a CAGR of 7.1% during 2021-2026.  

The influenza diagnostic market is segmented by molecular diagnostic tests into reverse transcription polymerase chain reaction (RT-PCR), isothermal nucleic acid amplification tests (INAAT), loop mediated isothermal based amplification assays, transcription mediated isothermal based amplification assays, other isothermal nucleic acid amplification tests, others. The reverse transcription polymerase chain reaction (RT-PCR) market was the largest segment of the influenza diagnostic market segmented by molecular diagnostic tests, accounting for 35.9% of the total in 2021 and is expected to be the fastest growing segment going forward, at a CAGR of 7.2% during 2021-2026.  

The influenza diagnostic market is segmented by end user into hospitals and clinical laboratories, diagnostic reference laboratories, academic/research institutes, other end users. The hospitals and clinical laboratories market was the largest segment of the influenza diagnostic market segmented by end user, accounting for 42.6% of the total in 2021 and diagnostic reference laboratories segment is expected to be the fastest growing segment going forward, at a CAGR of 7.1% during 2021-2026.  

North America was the largest region in the global influenza diagnostic market, accounting for 34.1% of the total in 2021. It was followed by Asia Pacific, Western Europe, and then the other regions. Going forward, the fastest-growing regions in the influenza diagnostic market will be South America and Asia Pacific, where growth will be at CAGRs of 8.3% and 7.4% respectively. These will be followed by North America and Western Europe, where the markets are expected to grow at CAGRs of 6.6% and 6.5% respectively, during 2021-2026.

The influenza diagnostic market is highly fragmented, with a large number of small players. The top ten competitors in the market made up to 43.74% of the total market in 2020. Major players in the market are Abbott Laboratories, F. Hoffmann-La Roche Ltd, Becton, Dickinson and Company, Thermo Fisher Scientific Inc, Quidel Corp, Danaher Corporation (Cepheid), Hologic Inc, DiaSorin S.p.A, GenMark Diagnostics, Inc and bioMerieux SA.

The top opportunities in the influenza diagnostic market segmented by traditional diagnostic tests will arise in the rapid influenza diagnostic tests (RIDT) segment, which will gain $347.4 million of global annual sales by 2026. The top opportunities in the influenza diagnostic market segmented by molecular diagnostic tests will arise in the reverse transcription polymerase chain reaction (RT-PCR) segment, which will gain $337.2 million of global annual sales by 2026. The top opportunities in the influenza diagnostic market segmented by end user will arise in the hospitals & clinical laboratories segment, which will gain $364.2 million of global annual sales by 2026. The influenza diagnostic market size will gain the most in the USA at $261.7 million.

Market-trend-based strategies for the influenza diagnostic market include strategic partnerships and acquisitions, use of artificial intelligence, collaborations between governments and manufacturers, at-home test kits, supportive government funding and initiatives.

Player-adopted strategies in the influenza diagnostic market include to focus on strengthening business by new product launches, focus on strengthening business globally and accelerate growth and expanding product portfolio by strategic partnership with companies.

To take advantage of the opportunities, Altus Market Research recommends the influenza diagnostics companies to focus on smartphone diagnostic apps, focus on expansion through collaborations, focus on technological improvement, establish operations in emerging markets, leverage growth in online sales post COVID-19, provide competitively priced offerings in low-income countries, focus on partnerships with end-users, leverage social media to maximize reach and focus on hospitals and other diagnostic centers.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Description:

Where is the largest and fastest growing market for influenza diagnostics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The influenza diagnostics market global report from Altus Market Research answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider influenza diagnostics market; and compares it with other markets.

The report covers the following chapters

Executive Summary – The executive summary section of the report gives a brief overview and summary of the report

Report Structure – This section gives the structure of the report and the information covered in the various sections.

Introduction – This section gives the segmentation of the influenza diagnostics market by geography, by traditional diagnostic tests, by molecular diagnostic tests and by end user covered in this report.

Market Characteristics – The market characteristics section of the report defines and explains influenza diagnostics market. This chapter also defines and describes goods and related services covered in the report.

Trends And Strategies – This chapter describes the major trends shaping the global influenza diagnostics market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.

Impact of COVID-19 – This section describes the impact of COVID-19 on the influenza diagnostics market.

Global Market Size And Growth – This section contains the global historic (2016-2021) and forecast (2021-2026, 2031) market values, and drivers and restraints that support and restrain the growth of the market in the historic and forecast periods.

Regional Analysis – This section contains the historic (2016-2021), forecast (2021-2026, 2031) market value and growth and market share comparison by region.

Segmentation – This section contains the market values (2016-2021, 2021-2026, 2031) and analysis for different segments in the market.

Regional Market Size and Growth – This section contains the region’s market size (2021), historic and forecast (2021-2026, 2031) market values, and growth and market share comparison of major countries within the region. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa).

Competitive Landscape – This section covers details on the competitive landscape of the global influenza diagnostics market, estimated market shares and company profiles for the leading players.

Danaher Corporation (Cepheid), Hologic Inc, DiaSorin S.p.A, GenMark Diagnostics, Inc, BioMerieux SA, Altona Diagnostics GmbH, Siemens Healthineers AG, Guangzhou Kingmed Diagnostics Group Co., Ltd, Harbin Fuerjia Technology Co., Ltd, Shanghai Labway Clinical Laboratory Co., Ltd, Shijiazhuang Yipai Biotechnology Co., Ltd, BioNTech, Pfizer, QIAGEN, Evotec, Morphosys, ELITech Group, Coris Bioconcept SPRL, Mast Group Ltd, Anwa-Tech Company, HELIMED Diagnostic, Medicalogrithmics, AeskuLab k.s, SPADIA LAB, a.s, Zdravotni ustav se sidlem v Usti nad Labem, Bio-Rad Laboratories, Meridian Bioscience, Inc, Clinica San Pablo S.A.C, Laboratorios Roe S.A, Unilabs Production Services S.A.C, Synlab Peu S.A.C, Diagnosticos da America S.A. (DASA), Fleury S.A, Centro de Imagem Diagnosticos S.A. (Alliar), Instituto Hermes Pardini S.A, NMC Healthcare, Al-Noor Medical Company, VPS Healthcare, Tumbay Group, Al-Zahra Group, Belhoul Lifecare, Emirates Healthcare, Gulf Healthcare International, Gulf Medical Projects Company, Zulekha Hospital, Saudi German Hospital Group, GE Healthcare, Aster DM Healthcare, Organic Chemistry Laboratory, AstraZeneca’s MedImmune unit, CSL, GlaxoSmithKline Plc, Novartis AG, Sanofi-Aventis SA

Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.

Market Opportunities And Strategies – This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.

Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for influenza diagnostics providers in terms of product/service offerings, geographic expansion, marketing strategies and target groups.

Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:
1) By Traditional Diagnostic Tests: Rapid Influenza Diagnostics Tests (RIDT); Viral Culture; DFA; Serological Assays; Other Traditional Diagnostic Tests
2) By Molecular Diagnostic Tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR); Isothermal Nucleic Acid Amplification Tests (INAAT); Loop Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Other Isothermal Nucleic Acid Amplification Tests; Other Molecular Diagnostic Tests
3) By End User: Hospitals And Clinical Laboratories; Diagnostic Reference Laboratories; Academic/Research Institutes; Other End Users

Companies Mentioned: Abbott Laboratories; F. Hoffmann-La Roche Ltd.; Becton, Dickinson and Company; Thermo Fisher Scientific Inc.; Quidel Corp

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; influenza diagnostics indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

1. Influenza Diagnostics Market Executive Summary
2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
6. Introduction
6.1.1. Segmentation By Geography
6.1.2. Segmentation By Traditional Diagnostic Tests
6.1.3. Segmentation By Molecular Diagnostic Tests
6.1.4. Segmentation By End-User
7. Influenza Diagnostics Market Characteristics
7.1. Market Definition
7.2. Segmentation By Traditional Diagnostic Tests
7.2.1. Rapid Influenza Diagnostic Tests (RIDT)
7.2.2. Viral Culture
7.2.3. DFA
7.2.4. Serological Assays
7.2.5. Others
7.3. Segmentation By Molecular Diagnostic Tests
7.3.1. Reverse Transcription Polymerase Chain Reaction (RT-PCR)
7.3.2. Isothermal Nucleic Acid Amplification Test
7.3.3. Loop-Mediated Isothermal Based Amplification Assays (LAMP)
7.3.4. Transcription Mediated Isothermal Based Amplification Assays
7.3.5. Other Isothermal Nucleic Acid Amplification Tests
7.4. Segmentation By End User
7.4.1. Hospitals and Clinical Laboratories
7.4.2. Diagnostic Reference Laboratories
7.4.3. Academic/Research Institutes
7.4.4. Others
8. Influenza Diagnostics Market Trends And Strategies
8.1. Strategic Partnerships and Acquisitions
8.2. Use Of Artificial Intelligence
8.3. Collaborations Between Governments And Manufacturers
8.4. At-Home Test Kits
8.5. Supportive Government Funding and Initiatives
9. Impact Of COVID-19 On Influenza Diagnostics Market
9.1. Introduction
9.2. Impact on Influenza Diagnostic Testing
9.3. Promotion Of Flu Vaccination During The COVID-19 Pandemic
9.4. Impact On Companies Revenue
9.5. Future Outlook
10. Global Influenza Diagnostics Market Size And Growth
10.1. Market Size
10.2. Historic Market Growth, 2016 – 2021, Value ($ Million)
10.2.1. Drivers Of The Market 2016 – 2021
10.2.2. Restraints On The Market 2016 – 2021
10.3. Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
10.3.1. Drivers Of The Market 2021 – 2026
10.3.2. Restraints On The Market 2021 – 2026
11. Global Influenza Diagnostics Market Segmentation
11.1. Global Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.2. Global Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.3. Global Influenza Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12. Influenza Diagnostics Market, Regional And Country Analysis
12.1. Global Influenza Diagnostics Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.2. Global Influenza Diagnostics Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13. Asia-Pacific Influenza Diagnostics Market
13.1. Asia-Pacific Influenza Diagnostics Market Overview
13.1.1. Region Information
13.1.2. Market Information
13.1.3. Background Information
13.1.4. Government Initiatives
13.1.5. Regulations
13.1.6. Regulatory Bodies
13.1.7. Major Associations
13.1.8. Taxes Levied
13.1.9. Corporate Tax Structure
13.1.10. Investments
13.1.11. Major Companies
13.2. Asia-Pacific Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
13.3. Asia-Pacific Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
13.4. Asia-Pacific Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13.5. Asia-Pacific Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13.6. China Influenza Diagnostics Market
13.7. China Influenza Diagnostics Market Overview
13.7.1. Country Information
13.7.2. Market Information
13.7.3. Background Information
13.7.4. Government Initiatives
13.7.5. Regulations
13.7.6. Regulatory Bodies
13.7.7. Major Associations
13.7.8. Taxes Levied
13.7.9. Corporate Tax Structure
13.7.10. Investments
13.7.11. Major Companies
13.8. China Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
13.9. China Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
13.10. China Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13.11. China Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13.12. India Influenza Diagnostics Market
13.13. India Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
13.14. India Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
13.15. India Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13.16. India Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13.17. Japan Influenza Diagnostics Market
13.18. Japan Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
13.19. Japan Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
13.20. Japan Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13.21. Japan Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13.22. Australia Influenza Diagnostics Market
13.23. Australia Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
13.24. Australia Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
13.25. Australia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13.26. Australia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13.27. Indonesia Influenza Diagnostics Market
13.28. Indonesia Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
13.29. Indonesia Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
13.30. Indonesia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13.31. Indonesia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13.32. South Korea Influenza Diagnostics Market
13.33. South Korea Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
13.34. South Korea Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
13.35. South Korea Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13.36. South Korea Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
14. Western Europe Influenza Diagnostics Market
14.1. Western Europe Influenza Diagnostics Market Overview
14.1.1. Region Information
14.1.2. Market Information
14.1.3. Background Information
14.1.4. Government Initiatives
14.1.5. Regulations
14.1.6. Regulatory Bodies
14.1.7. Major Associations
14.1.8. Taxes Levied
14.1.9. Corporate Tax Structure
14.1.10. Investments
14.1.11. Major Companies
14.2. Western Europe Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
14.3. Western Europe Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
14.4. Western Europe Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
14.5. Western Europe Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
14.6. Western Europe Influenza Diagnostics Market: Country Analysis
14.7. UK Influenza Diagnostics Market
14.8. UK Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
14.9. UK Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
14.10. UK Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
14.11. UK Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
14.12. Germany Influenza Diagnostics Market
14.13. Germany Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
14.14. Germany Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
14.15. Germany Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
14.16. Germany Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
14.17. France Influenza Diagnostics Market
14.18. France Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
14.19. France Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
14.20. France Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
14.21. France Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
15. Eastern Europe Influenza Diagnostics Market
15.1. Eastern Europe Influenza Diagnostics Market Overview
15.1.1. Region Information
15.1.2. Market Information
15.1.3. Background Information
15.1.4. Government Initiatives
15.1.5. Regulations
15.1.6. Regulatory Bodies
15.1.7. Major Associations
15.1.8. Taxes Levied
15.1.9. Corporate Tax Structure
15.1.10. Investments
15.1.11. Major Companies
15.2. Eastern Europe Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
15.3. Eastern Europe Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
15.4. Eastern Europe Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
15.5. Eastern Europe Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
15.6. Eastern Europe Influenza Diagnostics Market: Country Analysis
15.7. Russia Influenza Diagnostics Market
15.8. Russia Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
15.9. Russia Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
15.10. Russia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
15.11. Russia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
16. North America Influenza Diagnostics Market
16.1. North America Influenza Diagnostics Market Overview
16.1.1. Region Information
16.1.2. Market Information
16.1.3. Background Information
16.1.4. Government Initiatives
16.1.5. Regulatory Bodies
16.1.6. Regulations
16.1.7. Major Associations
16.1.8. Taxes Levied
16.1.9. Corporate tax structure
16.1.10. Investments
16.1.11. Major Companies
16.2. North America Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
16.3. North America Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
16.4. North America Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
16.5. North America Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
16.6. USA Influenza Diagnostics Market
16.7. USA Influenza Diagnostics Market Overview
16.7.1. Country Information
16.7.2. Market Information
16.7.3. Background Information
16.7.4. Government Initiatives
16.7.5. Regulatory Bodies
16.7.6. Regulations
16.7.7. Major Associations
16.7.8. Taxes Levied
16.7.9. Corporate Tax Structure
16.7.10. Investments
16.7.11. Major Companies
16.8. USA Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
16.9. USA Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
16.10. USA Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
16.11. USA Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
17. South America Influenza Diagnostics Market
17.1. South America Influenza Diagnostics Market Overview
17.1.1. Region Information
17.1.2. Market Information
17.1.3. Background Information
17.1.4. Government Initiatives
17.1.5. Regulations
17.1.6. Regulatory Bodies
17.1.7. Major Associations
17.1.8. Taxes Levied
17.1.9. Corporate Tax Structure
17.1.10. Investments
17.1.11. Major Companies
17.2. South America Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
17.3. South America Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
17.4. South America Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
17.5. South America Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
17.6. South America Influenza Diagnostics Market: Country Analysis
17.7. Brazil Influenza Diagnostics Market
17.8. Brazil Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
17.9. Brazil Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
17.10. Brazil Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
17.11. Brazil Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
18. Middle East Influenza Diagnostics Market
18.1. Middle East Influenza Diagnostics Market Overview
18.1.1. Region Information
18.1.2. Market Information
18.1.3. Background Information
18.1.4. Government Initiatives
18.1.5. Regulations
18.1.6. Regulatory Bodies
18.1.7. Major Associations
18.1.8. Taxes Levied
18.1.9. Corporate Tax Structure
18.1.10. Investments
18.1.11. Major Companies
18.2. Middle East Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
18.3. Middle East Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
18.4. Middle East Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
18.5. Middle East Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
19. Africa Influenza Diagnostics Market
19.1. Africa Influenza Diagnostics Market Overview
19.1.1. Region Information
19.1.2. Market Information
19.1.3. Background Information
19.1.4. Government Initiatives
19.1.5. Regulations
19.1.6. Regulatory Bodies
19.1.7. Major Associations
19.1.8. Taxes Levied
19.1.9. Corporate Tax Structure
19.1.10. Investments
19.1.11. Major Companies
19.2. Africa Influenza Diagnostics Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
19.3. Africa Influenza Diagnostics Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
19.4. Africa Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
19.5. Africa Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
20. Influenza Diagnostics Market Competitive Landscape And Company Profiles
20.1. Company Profiles
20.2. Abbott Laboratories
20.2.1. Company Overview
20.2.2. Products And Services
20.2.3. Business Strategy
20.2.4. Financial Overview
20.3. F. Hoffmann-La Roche Ltd
20.3.1. Company Overview
20.3.2. Products And Services
20.3.3. Business Strategy
20.3.4. Financial Overview
20.4. Becton, Dickinson and Company
20.4.1. Company Overview
20.4.2. Products And Services
20.4.3. Financial Overview
20.5. Thermo Fisher Scientific Inc
20.5.1. Company Overview
20.5.2. Products And Services
20.5.3. Business Strategy
20.5.4. Financial Overview
20.6. Quidel Corporation
20.6.1. Company Overview
20.6.2. Products And Services
20.6.3. Business Strategy
20.6.4. Financial Overview
21. Key Mergers And Acquisitions In The Influenza Diagnostics Market
21.1. Becton, Dickinson and Company Acquired Scanwell Health
21.2. Roche Acquired TIB Molbiol Group
21.3. Mylab Discovery Solutions Partnered With Hemex Health
21.4. Roche Acquired GenMark Diagnostics
21.5. Hologic Acquired Mobidiag Oy
21.6. DiaSorin Acquired Luminex
21.7. Thermo Fisher Acquired Mesa Biotech
21.8. Becton Dickinson Acquired NAT Diagnostics
21.9. Meridian Bioscience Inc Acquired GenePoc Inc
22. Influenza Diagnostics Market Opportunities And Strategies
22.1. Global Influenza Diagnostics Market In 2026 – Countries Offering Most New Opportunities
22.2. Global Influenza Diagnostics Market In 2026 – Segments Offering Most New Opportunities
22.3. Global Influenza Diagnostics Market In 2026 – Growth Strategies
22.3.1. Market Trend Based Strategies
22.3.2. Competitor Strategies
23. Influenza Diagnostics Market, Conclusions And Recommendations
23.1. Conclusions
23.2. Recommendations
23.2.1. Product
23.2.2. Place
23.2.3. Price
23.2.4. Promotion
23.2.5. People
24. Appendix
24.1. Market Data Sources
24.2. Research Methodology
24.3. Currencies
24.4. Research Inquiries
24.5. The Business Research Company
24.6. Copyright and Disclaimer
 


List of Tables

Table 1: Global Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
Table 2: Global Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
Table 3: Global Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 4: Global Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 5: Global Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 6: Global Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 7: Global Influenza Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 8: Global Influenza Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 9: Global Influenza Diagnostics Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
Table 10: Global Influenza Diagnostics Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 11: Global Influenza Diagnostics Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %
Table 12: Global Influenza Diagnostics Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 13: Asia-Pacific GDP Per Capita, By Country, 2016-2021, $
Table 14: Asia-Pacific Population By Age Group, By Country, 2016-2026, Thousands
Table 15: Asia-Pacific Public Healthcare Expenditure, 2015-2020, $ Billion
Table 16: Asia-Pacific Private Healthcare Expenditure, 2015-2020, $ Billion
Table 17: Asia-Pacific Healthcare Services, By Country, 2016-2026, $ Billion
Table 18: Asia-Pacific Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
Table 19: Asia-Pacific Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
Table 20: Asia-Pacific Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 21: Asia-Pacific Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 22: Asia-Pacific Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 23: Asia-Pacific Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 24: China GDP Per Capita, 2016-2021, $
Table 25: China Population By Age Group, 2016-2026, Thousands
Table 26: China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
Table 27: China Healthcare Services, 2016-2026, $ Billion
Table 28: China Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
Table 29: China Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
Table 30: China Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 31: China Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 32: China Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 33: China Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 34: India Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
Table 35: India Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
Table 36: India Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 37: India Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 38: India Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 39: India Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 40: Japan Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
Table 41: Japan Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
Table 42: Japan Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 43: Japan Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 44: Japan Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 45: Japan Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 46: Australia Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
Table 47: Australia Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
Table 48: Australia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 49: Australia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 50: Australia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 51: Australia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 52: Indonesia Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
Table 53: Indonesia Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
Table 54: Indonesia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 55: Indonesia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 56: Indonesia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 57: Indonesia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 58: South Korea Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
Table 59: South Korea Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
Table 60: South Korea Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 61: South Korea Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 62: South Korea Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 63: South Korea Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 64: Western Europe GDP Per Capita, By Country, 2016-2021, $
Table 65: Western Europe Population By Age Group, By Country, 2016-2026, Thousands
Table 66: Western Europe Public Healthcare Expenditure, 2015-2020, $ Billion
Table 67: Western Europe Private Healthcare Expenditure, 2015-2020, $ Billion
Table 68: Western Europe Healthcare Services, By Country, 2016-2026, $ Billion
Table 69: Western Europe Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
Table 70: Western Europe Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
Table 71: Western Europe Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 72: Western Europe Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 73: Western Europe Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 74: Western Europe Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 75: UK Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
Table 76: UK Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
Table 77: UK Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 78: UK Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 79: UK Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 80: UK Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 81: Germany Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
Table 82: Germany Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
Table 83: Germany Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 84: Germany Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 85: Germany Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 86: Germany Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 87: France Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
Table 88: France Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
Table 89: France Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 90: France Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 91: France Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 92: France Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 93: Eastern Europe GDP Per Capita, By Country, 2016-2021, $
Table 94: Eastern Europe Population By Age Group, By Country, 2016-2026, Thousands
Table 95: Eastern Europe Public Healthcare Expenditure, 2015-2020, $ Billion
Table 96: Eastern Europe Private Healthcare Expenditure, 2015-2020, $ Billion
Table 97: Eastern Europe Healthcare Services, By Country, 2016-2026, $ Billion
Table 98: Eastern Europe Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
Table 99: Eastern Europe Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
Table 100: Eastern Europe Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 101: Eastern Europe Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 102: Eastern Europe Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 103: Eastern Europe Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 104: Russia Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
Table 105: Russia Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
Table 106: Russia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 107: Russia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 108: Russia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 109: Russia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 110: North America GDP Per Capita, By Country, 2016-2021, $
Table 111: North America Population By Age Group, By Country, 2016-2026, Thousands
Table 112: North America Public Healthcare Expenditure, 2015-2020, $ Billion
Table 113: North America Private Healthcare Expenditure, 2015-2020, $ Billion
Table 114: North America Healthcare Services, By Country, 2016-2026, $ Billion
Table 115: North America Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
Table 116: North America Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
Table 117: North America Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 118: North America Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 119: North America Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 120: North America Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 121: USA GDP Per Capita, 2016-2021, $
Table 122: USA Population By Age Group, 2016-2026, Thousands
Table 123: USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
Table 124: USA Healthcare Services, By Country, 2016-2026, $ Billion
Table 125: USA Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
Table 126: USA Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
Table 127: USA Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 128: USA Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 129: USA Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 130: USA Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 131: South America GDP Per Capita, By Country, 2016-2021, $
Table 132: South America Population By Age Group, By Country, 2016-2026, Thousands
Table 133: South America Public Healthcare Expenditure, 2015-2020, $ Billion
Table 134: South America Private Healthcare Expenditure, 2015-2020, $ Billion
Table 135: South America Healthcare Services, By Country, 2016-2026, $ Billion
Table 136: South America Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
Table 137: South America Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
Table 138: South America Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 139: South America Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 140: South America Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 141: South America Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 142: Brazil Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
Table 143: Brazil Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
Table 144: Brazil Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 145: Brazil Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 146: Brazil Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 147: Brazil Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 148: Middle East GDP Per Capita, By Country, 2016-2021, $
Table 149: Middle East Population By Age Group, By Country, 2016-2026, Thousands
Table 150: Middle East Public Healthcare Expenditure, 2015-2020, $ Billion
Table 151: Middle East Private Healthcare Expenditure, 2015-2020, $ Billion
Table 152: Middle East Healthcare Services, By Country, 2016-2026, $ Billion
Table 153: Middle East Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
Table 154: Middle East Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
Table 155: Middle East Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 156: Middle East Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 157: Middle East Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 158: Middle East Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 159: Africa GDP Per Capita, By Country, 2016-2021, $
Table 160: Africa Population By Age Group, By Country, 2016-2026, Thousands
Table 161: Africa Public Healthcare Expenditure, 2015-2020, $ Billion
Table 162: Africa Private Healthcare Expenditure, 2015-2020, $ Billion
Table 163: Africa Healthcare Services, By Country, 2016-2026, $ Billion
Table 164: Africa Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million
Table 165: Africa Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million
Table 166: Africa Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 167: Africa Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 168: Africa Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
Table 169: Africa Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
Table 170: Global Influenza Diagnostics market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
Table 171: Abbott – Financial Performance, $ Billion
Table 172: Roche – Financial Performance, $ Billion
Table 173: BD – Financial Performance, $ Billion
Table 174: Thermo Fisher– Financial Performance, $ Billion
Table 175: Quidel – Financial Performance, $ Billion
Table 176: Global Influenza Diagnostics Market Size Gain ($ Million), 2021 – 2026, By Country
Table 177: Global Influenza Diagnostics Market Size Gain ($ Million), Segmentation By Traditional Diagnostic Tests, 2021 – 2026
Table 178: Global Influenza Diagnostics Market Size Gain ($ Million), Segmentation By Molecular Diagnostic Tests, 2021 – 2026
Table 179: Global Influenza Diagnostics Market Size Gain ($ Million), Segmentation By End-User, 2021 – 2026
Table 180: Influenza Diagnostics - Market Data Sources


List of Figures

Figure 1: Global Influenza Diagnostics Market Segmentation By Traditional Diagnostic Tests

Figure 2: Global Influenza Diagnostics Market Segmentation By Molecular Diagnostic Tests

Figure 3: Global Influenza Diagnostics Market Segmentation By End-User

Figure 4: Global Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million

Figure 5: Global Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million

Figure 6: Global Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 7: Global Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 8: Global Influenza Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 9: Global Influenza Diagnostics Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 10: Global Influenza Diagnostics Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 11: Asia-Pacific Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million

Figure 12: Asia-Pacific Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million

Figure 13: Asia-Pacific Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 14: Asia-Pacific Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 15: China Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million

Figure 16: China Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million

Figure 17: China Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 18: China Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 19: India Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million

Figure 20: India Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million

Figure 21: India Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 22: India Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 23: Japan Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million

Figure 24: Japan Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million

Figure 25: Japan Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 26: Japan Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 27: Australia Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million

Figure 28: Australia Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million

Figure 29: Australia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 30: Australia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 31: Indonesia Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million

Figure 32: Indonesia Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million

Figure 33: Indonesia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 34: Indonesia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 35: South Korea Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million

Figure 36: South Korea Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million

Figure 37: South Korea Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 38: South Korea Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 39: Western Europe Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million

Figure 40: Western Europe Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million

Figure 41: Western Europe Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 42: Western Europe Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 43: UK Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million

Figure 44: UK Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million

Figure 45: UK Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 46: UK Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 47: Germany Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million

Figure 48: Germany Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million

Figure 49: Germany Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 50: Germany Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 51: France Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million

Figure 52: France Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million

Figure 53: France Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 54: France Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 55: Eastern Europe Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million

Figure 56: Eastern Europe Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million

Figure 57: Eastern Europe Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 58: Eastern Europe Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 59: Russia Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million

Figure 60: Russia Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million

Figure 61: Russia Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 62: Russia Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 63: North America Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million

Figure 64: North America Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million

Figure 65: North America Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 66: North America Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 67: USA Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million

Figure 68: USA Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million

Figure 69: USA Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 70: USA Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 71: South America Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million

Figure 72: South America Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million

Figure 73: South America Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 74: South America Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 75: Brazil Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million

Figure 76: Brazil Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million

Figure 77: Brazil Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 78: Brazil Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 79: Middle East Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million

Figure 80: Middle East Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million

Figure 81: Middle East Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 82: Middle East Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 83: Africa Influenza Diagnostics Market, Historic, 2016 – 2021, $ Million

Figure 84: Africa Influenza Diagnostics Market, Forecast, 2021 – 2026, 2031F, $ Million

Figure 85: Africa Influenza Diagnostics Market, Segmentation By Traditional Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 86: Africa Influenza Diagnostics Market, Segmentation By Molecular Diagnostic Tests, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %

Figure 87: Global Influenza Diagnostics market, Key Competitor Estimated Market Shares, 2020, Percentage (%)

Figure 88: Abbott – Financial Performance, $ Billion

Figure 89: Roche – Financial Performance, $ Billion

Figure 90: BD – Financial Performance, $ Billion

Figure 91: Thermo Fisher– Financial Performance, $ Billion

Figure 92: Quidel – Financial Performance, $ Billion

Research methodology is mainly referring to the practical how of any offered piece of research. More specifically, it’s all about how a researcher systematically designs a study in order to assure extremely valid as well as reliable results that ultimately address the targets and objectives of the research.

In any formal research including academic journal, article, dissertation and so on, there will be a special section on a research methodology that mainly describes what, by whom, how to gather as well as how to evaluate the data are provided.

This research methodology has been segmented into following types:

Primary Research:

It is said to be original information that the researchers collect for the crucial purposes of answering the research questions of readers with the help of surveys, observations and experiments.

Secondary Research:

The secondary research is the data that has already been collected by various other researchers in the form of government analysis or scientific studies.

Qualitative Research:

It is descriptive and subjective method irrespective of facts. Both observation and description are essential in this type of research methodology. Its main vision is to analyze knowledge, attitudes, behaviours as well as opinions of people related to the topic of any research. This method has been operated through grounded research, case study and actionable research.

Quantitative Research:

It contains several laboratory experiments, basic surveys, mathematical calculations, simulations and so on. The possible measurement, quantity or amount is considered to be a major factor in the quantitative research methodology.

Tab Four
Our Happy

Clients